《Seminars In Oncology》重点专注发布医学-肿瘤学领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在医学-肿瘤学领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 6.6 | 1.032 | 0.889 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Hematology
|
Q1 | 34/137 | 75% | |||
|
大类：大类：Medicine
小类：小类：Oncology
|
Q2 | 108/404 | 73% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ONCOLOGY | SCIE | Q2 | 142 / 322 | 56.1% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ONCOLOGY | SCIE | Q3 | 241 / 322 | 25.31% |
文章名称
引用次数
FDA analyses of survival in older adults with metastatic non-small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies
20
Neoadjuvant Treatment for Pancreatic Cancer
19
Electrochemotherapy of superficial tumors - Current status: Basic principles, operating procedures, shared indications, and emerging applications
19
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib
16
Systemic treatment of pancreatic cancer revisited
16
Clinical applications of proton and carbon ion therapy
14
Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy
12
Nutritional status and clinical outcomes in pediatric patients with solid tumors : A systematic review of the literature
12
Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer
11
Significance of TIM3 expression in cancer: From biology to the clinic
11
国家/地区
发文量
TUSA
75
TItaly
32
TCuba
12
TEngland
11
TAustralia
9
TPoland
7
TIndia
6
TBelgium
5
TFrance
4
TGERMANY (FED REP GER)
4
